Champions Oncology Reports Record Revenue of $59.4M and Positive EBITDA

Champions Oncology reported fiscal year 2026 record revenue of $59.4 million and positive Adjusted EBITDA for the fiscal year, despite the absence of prior-year licensing revenue. The company continues to invest in its radiopharmaceuticals and data platforms.